Viewing data from:

CEVIMELINE HYDROCHLORIDE

ANDA

CEVIMELINE HYDROCHLORIDE | A091591 | HIKMA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: EVOXAC(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.6871

per ea

Lowest NADAC/Unit

$0.6871

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00054033425CEVIMELINE HCL 30 MG CAPSULE	$0.6871	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$98.49

Highest Price

$98.49

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00054-0334-25CEVIMELINE HCL 30MG CAP	$98.49	FSS	Hikma Pharmaceuticals USA Inc.	08/14/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs

7 active API suppliers hold Drug Master Files for this ingredient.

ISHIHARA SANGYO KAISHA LTDCEVIMELINE HYDROCHLORIDE

DMF 130741998

EXCELLA GMBH AND CO KGCEVIMELINE HYDROCHLORIDE

DMF 222002008

APOTEX INCCEVIMELINE HYDROCHLORIDE HEMIHYDRATE

DMF 225092009

MATRIX PHARMACORP PRIVATE LTDCEVIMELINE HYDROCHLORIDE USP

DMF 249492011

STHREE CHEMICALS LLCCEVIMELINE HYDROCHLORIDE USP

DMF 385772023

KALINTIS HEALTHCARE PVT LTDCEVIMELINE HYDROCHLORIDE USP

DMF 388802023

APICORE LLCCEVIMELINE HYDROCHLORIDE USP

DMF 402232024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 30MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jul 8, 2013

No patent or exclusivity listings for this strength.